Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 7473525!?!7473525 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=7473525&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Hum+Hypertens 1995 ; 9 (6): 443-6 Nephropedia Template TP {{tp|p=7473525|t=1995. Mineralocorticoid receptor blockade in chronic heart failure |pdf=|usr=}}{{7473525}} gab.com Text Mineralocorticoid receptor blockade in chronic heart failure JO: J Hum Hypertens http://www.kidney.de/pget.php?&tw=1&pmid=7473525 #FOAvip The effects of ACE inhibitors on plasma aldosterone in chronic heart failure are poor, variable and unsustained. This is important to recognise because aldosterone has many harmful properties of its own. Aldosterone causes magnesium loss, potentiates catecholamines, induces ventricular arrhythmias, alters baroreflex function and stimulates myocardial fibrosis. Strategies to reduce these effects of aldosterone are being explored. Twit Text FOAVip Mineralocorticoid receptor blockade in chronic heart failure ????J Hum Hypertens http://www.kidney.de/pget.php?&tw=1&pmid=7473525 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=7473525 #FOAvip English Wikipedia <ref>{{Cite pmid|7473525}}</ref> Mineralocorticoid receptor blockade in chronic heart failure #MMPMID7473525 Struthers AD J Hum Hypertens 1995[Jun]; 9 (6): 443-6 PMID7473525show ga The effects of ACE inhibitors on plasma aldosterone in chronic heart failure are poor, variable and unsustained. This is important to recognise because aldosterone has many harmful properties of its own. Aldosterone causes magnesium loss, potentiates catecholamines, induces ventricular arrhythmias, alters baroreflex function and stimulates myocardial fibrosis. Strategies to reduce these effects of aldosterone are being explored. |*Mineralocorticoid Receptor Antagonists[MESH] |Angiotensin-Converting Enzyme Inhibitors/therapeutic use[MESH] |Arrhythmias, Cardiac/etiology/physiopathology[MESH] |Cardiac Output, Low/drug therapy/*metabolism[MESH] |Catecholamines/physiology[MESH] |Chronic Disease[MESH] |Drug Synergism[MESH] |Fibrosis[MESH] |Humans[MESH] |Magnesium/metabolism[MESH] |Myocardium/pathology[MESH] |Pressoreceptors/physiology[MESH]Mineralocorticoid receptor blockade in chronic heart failure (epmc).pdf DeepDyve Pubget Overpricing